MIRA Pharmaceuticals, Inc. (MIRA) Q4 2024 Annual Earnings
MIRA·Reported March 28, 2025·Before market open
MIRA Pharmaceuticals, Inc. reported Q4 2024 revenue of $11.2M. Diluted EPS came in at $-0.15, beat the $-0.29 consensus by $0.14.
Revenue
$11.2M
Diluted EPS
$-0.15beat by $0.14
Consensus: $-0.29
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about MIRA Pharmaceuticals, Inc.'s Q4 2024 earnings report.
MIRA Pharmaceuticals, Inc. (MIRA) reported Q4 2024 earnings on March 28, 2025 before market open.
MIRA Pharmaceuticals, Inc. reported revenue of $11.2M and diluted EPS of $-0.15 for Q4 2024.
EPS beat the consensus estimate of $-0.29 by $0.14.
You can read the 10-K periodic report (0001641172-25-001183) directly on SEC EDGAR. The filing index links above go to sec.gov.